The Types category within Dental Bone Graft Void Filler market taxonomy classifies products by biological origin: Autograft, Allograft, Xenograft, and Alloplast. Autografts, harvested from the patient’s own bone, occupy a modest niche because of limited supply and donor‑site morbidity, yet they retain premium pricing due to osteogenic potential. Allografts, derived from human donors, dominate the market by volume, offering a balance of availability and biocompatibility that aligns with the majority of implant‑site procedures. Xenografts, typically bovine‑derived, provide a porous scaffold that supports rapid vascularization, making them the preferred choice for sinus augmentation and ridge preservation where structural stability is critical. Alloplasts, synthetic calcium‑phosphate or bioactive glass materials, are gaining traction for their predictable resorption rates and absence of disease‑transmission risk, especially in periodontal regeneration. Each type’s market contribution is calibrated to clinical efficacy, regulatory pathways, and cost considerations, shaping the overall market composition.